Figure 2.

Adalimumab plus methotrexate in active rheumatoid arthritis: mean change from baseline in total Sharp score. *P < 0.01, P ≤ 0.001, versus placebo. MTX, methotrexate. Reproduced with permission [18]. Copyright © 2004 by John Wiley & Sons, Inc.

Moreland Arthritis Research & Therapy 2005 7(Suppl 3):S2-S8   doi:10.1186/ar1736